Please provide your email address to receive an email when new articles are posted on . In an analysis of data from two phase 3, multicenter studies of 1,217 adult patients randomized to the ...

Richard Adler, MD, FACS, leads a discussion on real-world signs, symptoms and patient reactions associated with the treatment for DED. This is a video synopsis/summary of a Post Conference ...

Signs and symptoms of ocular surface disease could be significantly reduced within 4 days after treatment with shelf-stable ...

If you have dry eye, you know how uncomfortable it can be. Dry eye disease happens when your eyes do not make enough quality tears or when your tears dry out too quickly. This can lead to eye ...

Hi, I am John Hovanesian. At the American Academy of Ophthalmology meeting in San Francisco, I presented a study that we did over the past year or so with my colleagues, Tom Chester [MD, of the ...

Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye. This was a phase 4, single-arm, multicenter ...

Oculis is forging ahead with its precision medicine approach to treating dry eye disease, outlining plans to finalize a phase 3 study after seeing some signs of efficacy in a subpopulation in its ...